Who makes MC2-01 Cream, no irradiation?

MC2-01 Cream, no irradiation is developed by MC2 Therapeutics.

What development phase is MC2-01 Cream, no irradiation in?

MC2-01 Cream, no irradiation is in Phase 1.

Last reviewed 2026-05-15 · How we verify

MC2-01 Cream, no irradiation

MC2 Therapeutics · Phase 1 active Small molecule

At a glance

Generic name	MC2-01 Cream, no irradiation
Sponsor	MC2 Therapeutics
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream (PHASE1)
Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MC2-01 Cream, no irradiation CI brief — competitive landscape report
MC2-01 Cream, no irradiation updates RSS · CI watch RSS
MC2 Therapeutics portfolio CI